Gallium ga 68 dotatate Alternatives Compared
| Gallium ga 68 dotatate | Neuraceq (florbetaben f-18) | Rubidium chloride rb-82 |
|
|---|
| Gallium ga 68 dotatate | Neuraceq (florbetaben f-18) | Rubidium chloride rb-82 |
|
|---|---|---|---|
|
Prescription only
Prescribed for Positron Emission Tomography Imaging. Gallium ga 68 dotatate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Positron Emission Tomography Imaging. Neuraceq may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Positron Emission Tomography Imaging. Rubidium chloride rb-82 may also be used for purposes not listed in this medication guide. |
Related suggestions Positron Emission Tomography Imaging
|
| More about Gallium ga 68 dotatate | More about Neuraceq (florbetaben f-18) | More about Rubidium chloride rb-82 | |
| Ratings & Reviews | |||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
|
View all Gallium ga 68 dotatate side effects |
View all Neuraceq side effects |
View all Rubidium chloride rb-82 side effects |
|
| Drug Class | |||
| Generic Availability | |||
|
N/A |
N/A |
||
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |||
|
N/A |
N/A |
N/A |
|
| Brand Names | |||
| Netspot |
N/A |
Cardiogen-82, Ruby-Fill | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
|
1.13 hours |
1 hour |
0.02 hours |
|
| CSA Schedule 1 View glossary of CSA terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
|
| Drug Interactions | |||
|
A total of 3 drugs are known to interact with Gallium ga 68 dotatate:
|
A total of 1 drugs are known to interact with Neuraceq:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | |||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| First Approval Date | |||
|
N/A |
March 19, 2014 |
December 29, 1989 |
|
| WADA Class View classifications | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient Resources | |||
| Professional Resources | |||
|
N/A |
N/A |
||
| Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.